7B: Drug Delivery SIG 4: Precision Nanomedicine for Cancer and Inflammatory Disease

This session will survey the diverse range of contemporary drug delivery systems and innovations. Drug delivering biomaterials can include nanoparticles, hydrogels, nanofibers, cell and virus-derived particles, or bioconjugates. Payloads can include DNA, RNA, antibodies, recombinant proteins, or small molecules. Disease applications can range from neurodegeneration to autoimmune disease, trauma, infection, or cancer. Work at all scales, from basic formulation science through therapeutic application in disease models is welcome. Studies that critically evaluate the impact of injection route on treatment efficacy and/or use novel imaging modalities to evaluate drug delivery performance are especially encouraged.

Moderators:

John Clegg
Assistant Professor
Gallogly College of Engineering
Peggy and Charles Stephenson
School of Biomeical Engineering
The University of Oklahoma

Cynthia Okafor
The University of Iowa | Office of Innovation

Aliasger Salem, Ph.D
Lyle and Sharon Bighley Endowed Chair & Professor / Associate Vice President for Research
University of Iowa | College of Pharmacy